A Prospective, Multi-CenterTrial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

Grants and Contracts Details

StatusFinished
Effective start/end date6/25/12 → 12/31/17

Funding

  • Novocure Ltd: $172,539.00